Next-generation Cancer Diagnostics Market: Latest Trends and Forecast Analysis upto 2024

Transparency Market Research Report Added "Next-generation Cancer Diagnostics Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2016 - 2024"

The cancer diagnostics industry is projected to witness lucrative growth in the next few years due to the increasing number of technologically advanced products providing accurate test results in the field of diagnostics. Additionally, they also help with therapeutic monitoring and early diagnosis of cancer. Significant improvements observed in the shift from traditional laboratory testing to rapid point of care testing (POC) drive this market.

Commercialization of products such as diagnostic kits, instruments, reagents, and consumables plays a role as well. The decreasing cost of genetic sequencing, rising incidence of cancer, increasing interest in the microfluidic hip technology, and the use of circulating tumor cells (CTCs) in cancer management have also aided the development of the next-generation cancer diagnostics market.

Government measures taken by developed and developing countries to increase the number of research projects in accordance with oncology and preventative diagnosis are anticipated to propel the next-generation cancer diagnostics market over the next few years. The application of tumor diagnostics in the epigenetic analysis and CTC enumeration sectors to monitor tumorigenesis is predicted to make a difference as well. However, the market may be limited by the high laboratory infrastructure costs involved. Insufficient reimbursement policies for innovative technologies and the stringent regulatory procedures and guidelines followed by the government are other factors affecting the global next-generation cancer diagnostics market.

This market is segmented by technology into the following categories: qPCR & multiplexing, protein microarrays, next-generation sequencing (NSG), DNA microarrays, lab-on-a-chip, and reverse transcriptase-PCR (RT-PCR), of which microarrays and PCR are expected to dominate the market due to their rising usage in invitro diagnostics by hospitals and private diagnostics clinics.

Based on application, the next-generation cancer diagnostics market is classified into the following groups: genetic analysis, biomarker development, epigenetic analysis, and CTC analysis & proteomic analysis, of which biomarkers and CTC analysis are likely to drive the market as these techniques are widely used in drug discovery and development.

The market, in terms of cancer type, is divided into the cervical, breast, colorectal, lung, and other varieties. Its function-based divisions are cancer screening, companion diagnostics, therapeutic monitoring, prognostics, and risk analysis, of which diagnostics and therapeutic monitoring are projected to be the leading segments.

Fill the form to gain deeper insights on this market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=19568

Geographically the next-generation cancer diagnostics market is distributed over North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is anticipated to dominate the market due to favorable government initiatives (such as the “80% by 2018” movement for colon cancer detection), healthy R&D investments, personalized medicine, development of next-generation sequencing, and availability of a technologically advanced health care research framework. The market in Asia Pacific is projected to register a prominent growth rate owing to the development of health care infrastructure, significantly large untapped market base, and economic development in the region.

Prominent players in the next-generation cancer diagnostics market include Thermo Fisher Scientific, Inc; Opko Health, Inc; Myriad Genetics, Inc.; Agilent Technologies; GE Healthcare Cepheid; Koninklijke Philips N.V; F. Hoffmann-La Roche Ltd; Qiagen; Novartis AG; Abbott; PerkinElmer, Inc.; Genomic Health, Inc.; Illumina, Inc; and Sysmex Corporation.


Contact Details

Company Name: Transparency Market Research
Issued By: Pooja M
Phone: 5186181030
Address: State Tower, 90 State Street, Suite 700
City: Albany,
State: New York
Zip: 12207
Country: United States
Website: Visit the website

Keywords : Next-generation Cancer Diagnostics Market,

by Pooja M (few months ago!)

Latest Press Releases

Text My Main Number Announced Major Shift of US Businesses toward Landline Texting

Global Department Stores Retailing 2015-2020: Ken Research

Global M-Health Device Market : Latest Research

Global Zinc Selenide Market Professional Survey Report 2017 to its Products Forecast – RAIN G..

Diesel Fuel Injection Systems 2017 Development, Trends, Share, Growth, Research and Market An..

Global Soil Testing, Inspection, and Certification Market Size, Status – ALS Ltd, Assure Qual..

Silicon Carbide Ceramics 2017 Annual Growth Value, Market Trends, Developments & Opportunities

5.1% CAGR Anticipated for Demineralized Whey Powder Ingredient Market During 2017-2027

Acoustic Wall Panels Market Forecasts, Size, Share, Regional Outlook 2017 to 2022

Rehm goes India

Remove this press release ?

Due to extra work required to remove the press-releases we have started charging $1.99 for press release removal.

Your press release will be removed in 24 hours, once the payment has been received.

Search Press Release
e.g. Business, Computer, etc.